Inotiv 2023 Investor Presentation

Inotiv is a global contract research organization (CRO) providing comprehensive research science, models, and services for novel therapeutic discovery and development. The company operates two segments: Research Models and Services (RMS) and Discovery and Safety Assessment (DSA), serving over 3,500 clients globally following 14 completed acquisitions since 2018.